Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 02 through its relevant journals, 09 Conferences, 08 workshopsare presently dedicated exclusively to Antiretroviral Therapy and about 93 articles are being published on Antiretroviral Therapy.
ARV, drugs are chosen on the basis of treatment guidelines, HIV drug resistance, your health (for example, kidney or liver disease) and lifestyle factors. While ARV regimens are usually well tolerated, each ARV drug can have side effects. Some may be serious. Refer to the fact sheet for each individual drug. Each person is different, and you and your health care provider will have to decide which drugs to use. Adherence to ARVs is very important for treatment to work. The viral load test is used to see if ARV drugs are working.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
There are treatments for HIV that can control the virus and help you stay healthy. Treatment can help people at any stage of HIV disease, even AIDS, but it is NOT a cure. The medications are called either Highly Active Antiretroviral Therapy (HAART) or Active Antiretroviral Therapy (ART). The use of less than three active agents is not recommended for initiating treatment. These agents belong to six distinct classes of drugs the nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs, NtRTIs), the non-nucleoside reverse transcriptase inhibitors (NNRTIs), the protease inhibitors (PIs), the fusion inhibitors (FIs), the CCR5 co-receptor antagonists, and the integrase strand transfer inhibitors (INSTIs).
ART are medications that treat HIV. The drugs do not kill or cure the virus. However, when taken in combination they can prevent the growth of the virus. When the virus is slowed down, so is HIV disease. Antiretroviral drugs are referred to as ARV. Combination ARV therapy (cART) is referred to as highly active ART (HAART). Antiretroviral drugs are usually used in combinations of three or more drugs from more than one class. This is called "Combination Therapy." Combination therapy helps prevent drug resistance. Manufacturers of ARVs keep trying to make their drugs easier to take, and have combined some of them into a single tablet regimen. In word ARVs reduce the viral load, the amount of virus in your bloodstream, but are not a cure. A blood test measures the viral load. People with undetectable viral loads stay healthier longer. They are also less likely to transmit HIV infection to others.Some people’s viral load is so low that it is “undetectable” by the viral load test. This does not mean that all the virus is gone, and it does not mean a person is cured of HIV infection.
The market for breathing disorder The most recent estimate we've found of drug costs comes from The Global Fund to Fight Aids, Tuberculosis and Malaria, which reports median expenditures on drugs of $188 per person per year of first-line ART drugs, and $588 per person per year for all ART program costs across its large, broad global project portfolio. In 2007, the cost of a year's worth of ART was $299 for first-line drugs and $709 for second-line drugs. The Disease Control Priorities Report estimates that ART costs $350-$1,494 per disability-adjusted life-year (DALY) averted in Sub-Saharan Africa. This is equivalent (from a simple conversion calculation)27 to $129.50-$552.78 per year spent on ART
International symposium and workshops:
Relevant Society and Associations:
List of Journals:
This page will be updated regularly.
This page was last updated on October 24, 2021